Literature DB >> 19565546

Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis.

Ulrich Weber1, Walter P Maksymowych, Anne G Jurik, Christian W A Pfirrmann, Kaspar Rufibach, Rudolf O Kissling, Muhammad A Khan, Robert G W Lambert, Juerg Hodler.   

Abstract

OBJECTIVE: To compare the performance of whole-body magnetic resonance imaging (MRI) versus conventional MRI in assessing acute inflammatory lesions of the sacroiliac (SI) joints in patients with established and active spondylarthritis (SpA) using the Spondyloarthritis Research Consortium of Canada (SPARCC) MRI index. This study is validating whole-body MRI against the current MRI standard for assessing active inflammatory lesions of the SI joints in patients with SpA.
METHODS: Thirty-two SpA patients with clinically active disease (Bath Ankylosing Spondylitis Disease Activity Index score >/=4) fulfilling the modified New York criteria were scanned by whole-body and conventional MRI of the SI joints. The MRIs were scored independently in random order by 3 readers blinded to patient identity. Active inflammatory lesions of the SI joints were recorded on a Web-based SPARCC index. Pearson's correlation coefficients were used to compare scores for whole-body and conventional MRI for each reader, whereas intraclass correlation coefficients (ICCs) were used to compare interobserver reliability.
RESULTS: The Pearson's correlation coefficients between whole-body and conventional MRI per rater were 0.94, 0.87, and 0.93. The mean sum scores for conventional versus whole-body MRI were statistically significantly higher for all 3 readers, although all patients showing inflammatory lesions on conventional MRI also demonstrated them on whole-body MRI. The ICCs(2,1) were 0.69, 0.78, and 0.95 for conventional MRI, and 0.79, 0.85, and 0.96 for whole-body MRI for the 3 possible reader pairs.
CONCLUSION: Whole-body and conventional MRI scores show a strong correlation and comparable reliability for the detection of inflammatory lesions of the SI joints.

Entities:  

Mesh:

Year:  2009        PMID: 19565546     DOI: 10.1002/art.24542

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Diagnostic utility of MRI in early spondyloarthritis.

Authors:  Walter P Maksymowych; Ulrich Weber
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

Review 2.  Early axial spondyloarthritis.

Authors:  Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

3.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 6 Diagnostics].

Authors:  U Kiltz; M Rudwaleit; J Sieper; D Krause; K-G Hermann; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

4.  Whole body MRI in spondyloarthritis (SpA): Preliminary results suggest that DWI outperforms STIR for lesion detection.

Authors:  Frederic E Lecouvet; Nicolas Vander Maren; Laurence Collette; Nicolas Michoux; Perrine Triqueneaux; Maria Stoenoiu; Frederic Houssiau; Jacques Malghem; Marie-Laurence Denis; Ahmed Larbi; Adrien Nzeusseu Toukap
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

Review 5.  The impact of MRI on the clinical management of inflammatory arthritides.

Authors:  Ulrich Weber; Mikkel Østergaard; Robert G W Lambert; Walter P Maksymowych
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

6.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

7.  Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study.

Authors:  Ulrich Weber; Robert Gw Lambert; Kaspar Rufibach; Walter P Maksymowych; Juerg Hodler; Anna Zejden; Stefan Duewell; Rudolf O Kissling; Paul L Filipow; Anne G Jurik
Journal:  Arthritis Res Ther       Date:  2012-01-06       Impact factor: 5.156

8.  Imaging the spine in arthritis-a pictorial review.

Authors:  Anne Grethe Jurik
Journal:  Insights Imaging       Date:  2011-01-08

9.  Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.

Authors:  I-H Song; Kg Hermann; H Haibel; C E Althoff; Ce Althoff; J Listing; Gr Burmester; A Krause; M Bohl-Bühler; B Freundlich; M Rudwaleit; J Sieper
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

10.  Imaging in rheumatology: reconciling radiology and rheumatology.

Authors:  Bernhard J Tins; Robin Butler
Journal:  Insights Imaging       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.